Corporate governance

General meeting

EGM 2020 notice to shareholders, 13 November 2020
EGM 2020 notice to shareholders, 28 October 2020
Proxy and correspondence form (DK)
Proxy and correspondence form (UK)
EGM 2020 notice to shareholders, 16 September 2020
Schedule 2 Warrant terms Board Warrants
Schedule 3 Warrant terms CEO Retainer Warrants
Schedule 4 Warrant terms CEO Event Warrants
Schedule 5 Warrant terms Employee Retainer Warrants
Schedule 6 Warrant terms Employee Event Warrants
EGM 2020 notice to shareholders, 16 September 2020 – IN SWEDISH
Presentaion Ordinary general meeting, 27 May 2020
Minutes of ordinary general meeting, 27 May 2020
AGM notice to shareholders, 27 May 2020
Minutes of extraordinary general meeting, 11 June 2019
EGM 2019 notice to shareholders, 11 June 2019
Minutes of ordinary general meeting, 29 May 2019
AGM notice to shareholders, 29 May 2019
Extraordinary General Meeting, 5 July 2018
Extraordinary General Meeting, 4 May 2018
Annual General Meeting, 23 March 2018

Articles of Association

Articles of Association, 13 november 2020
Articles of Association, 05 October 2020
Articles of Association, 27 May 2020
Articles of Association, 12 July 2019

Auditor

Deloitte Statsautoriseret Revisionspartnerselskab
Weidekampsgade 6
Postboks 1600
2300 København S

Scandion Oncology Investor Relations

Bo Rode Hansen, CEO
E: info@scandiononcology.com
T: +45 38 10 20 17

Investor information

Spotlight
Waterfront Building
Klarabergsviadukten 63, 9 tr
101 23 Stockholm
Sweden

Phone: +46 8 511 68 000
Website: www.spotlightstockmarket.com

Qualified Adviser

Sedermera Fondkommission
Norra Vallgatan 64
211 22 Malmö
Sweden

Phone: + 46 406151410
Website: www.sedermera.se

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union
Privacy and Cookie Policy